Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.76 USD | +6.78% | +14.32% | -4.81% |
Financials (USD)
Sales 2024 * | 132M | Sales 2025 * | 210M | Capitalization | 2.67B |
---|---|---|---|---|---|
Net income 2024 * | -280M | Net income 2025 * | -133M | EV / Sales 2024 * | 17.1 x |
Net cash position 2024 * | 416M | Net cash position 2025 * | 288M | EV / Sales 2025 * | 11.3 x |
P/E ratio 2024 * |
-10.5
x | P/E ratio 2025 * |
-21.8
x | Employees | 226 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.1% |
Latest transcript on Rhythm Pharmaceuticals, Inc.
1 day | +6.78% | ||
1 week | +14.32% | ||
Current month | +10.06% | ||
1 month | +9.13% | ||
3 months | -2.50% | ||
6 months | +62.25% | ||
Current year | -4.81% |
Managers | Title | Age | Since |
---|---|---|---|
David Meeker
CEO | Chief Executive Officer | 69 | 15-10-31 |
Hunter Smith
DFI | Director of Finance/CFO | 56 | 17-06-30 |
Joseph Shulman
CTO | Chief Tech/Sci/R&D Officer | 49 | 20-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christophe Jean
BRD | Director/Board Member | 67 | 15-03-31 |
Jennifer Good
BRD | Director/Board Member | 59 | 19-06-18 |
David McGirr
BRD | Director/Board Member | 69 | 15-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | 0.00% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.09% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 43.76 | +6.78% | 920,780 |
24-05-02 | 40.98 | -1.09% | 427,645 |
24-05-01 | 41.43 | +4.20% | 1,030,711 |
24-04-30 | 39.76 | +2.42% | 628,635 |
24-04-29 | 38.82 | +1.41% | 280,302 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.81% | 2.67B | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- RYTM Stock